According to the research report titled ‘Vitamin K Market Size By Type (Vitamin K1, Vitamin K2), By Application, By Route of Administration (Oral, Parenteral, Topical) Industry Analysis Report, Regional Outlook  Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report, global vitamin K market is projected to grow substantially between 2019-2025, accumulating USD 1 billion by the end of forecast period.
 

Increasing cases of coagulation disorder resulting in hemorrhage, thrombosis, and other chronic ailments, along with cognizance about effectiveness of product for treating the same are driving global vitamin K market expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2212521/
 

Moreover, rising consumption of junk food in developed economies coupled with changing lifestyles will result in susceptibility to chronic diseases, while malnourishment among people in emerging economies will cause coagulation disorders. These factors will raise the demand for vitamin K supplements.
 

Based on type, the market sphere is bifurcated into vitamin K1 and vitamin K2. The report cites that vitamin K1 segment was worth USD 400 million in 2018 and is poised to grow further in the upcoming years. Vitamin K1 aids absorption of calcium phosphate in bones and its deficiency adversely impacts bone and teeth development.
 

Speaking of application scope, worldwide vitamin K industry share from vitamin K deficiency bleeding (VKDB) segment is anticipated to grow with a CAGR of 8.5% through 2025. VKDB is observed in infants and increases the risk of fatal hemorrhages. Hence, emphasis on administering vitamin K dosage in new-borns to avert any form of VKDB is impelling the segmental growth.
 

Moving on to administration route, parental segment generated revenues around USD 160 million for global vitamin K market in 2018 and is slated to showcase lucrative growth trends, owing to enhanced bioavailability of these formulations resulting in quick delivery of required dose at action site.
 

Regionally speaking, vitamin K industry size in Latin America is projected to expand at an annual rate of 9% between 2019-2025. Policies and programs run by the government to eradicate health related problems and reduce occurrence of micronutrient deficiency will facilitate this growth. Moreover, developed healthcare infrastructure, in consort with measures taken to improve awareness among populace regarding negative effects of micronutrients deficiency will also boost vitamin K industry expansion in LATAM.
 

Leading players influencing global vitamin K market dynamics are Country Life LLC, BASF SE, NattoPharma ASA, Solgar Inc., Kappa Bioscience AS, NOW Foods, Pfizer Inc., Amphastar Pharmaceuticals Inc., Koninklijke DSM N.V., and Livealth Biopharma Pvt. Ltd.